Long for a Longtime or until they make me an offer I cant' Refuse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Same rules were in effect then...The buys that he made last year were totally legal. Be informed before you speak.
If we have the Goods...the $$$$ will come..
Retts and other indications represent a faster path to commercialization...
The AD trials will only create more interest..IMO
I received this on my phones news feed this morning....Talk about desperation (2011, 2012 really!)...shorts are getting nervous....
http://reviewfortune.com/2016/07/08/anavex-life-sciences-corp-nasdaqavxl-updated-analyst-ratings/
Wrong again!
AAIC
Safety and Efficacy 31 Week Data of Anavex 2-73 in a Phase 2a Study in Mild-Moderate Alzheimer’s Disease Patients
LOL! Now that was funny!
Great news do you have a link. thanks
5 min chart looked positive.
Nice dump!
heads or tails...lol
If late breaking PR comes out your charts are meaningless!
I agree George.... Retts is the path of least resistance to commercialization... Drug is safe...
One time slot open on Mon. July 25th 3:15 to 3:30 under the subtopic Dementia Care Practice: Innovative Programs and System Improvements... Just happens to be the topic and subtopic of the good doctors 2nd Poster... Coincidence?
After looking at the info. I believe the late breaking oral presentation could be scheduled in the Dementia Care Practice Track.
I found it interesting it wasn't listed under posters for those two days.
Second poster is titled Dementia Care Practice...
That is my point...the 27th is a poster not an oral presentation and the poster does not show up under the Dementia Care Research and Practice Track. May mean nothing but.....
http://alz.org/aaic/program/dementia-care-overview.asp
Notice the sub topic of the second poster .... Dementia Care Practice
The sessions on July 25 and 26 (Monday and Tuesday) will feature the latest research and updates regarding epidemiology, health economics, policy and psychosocial factors related to dementia, and innovative dementia care practices
Selection of Presentations
For the two-day Dementia Care Research and Practice Track, the research presentations will be selected by the Scientific Program Committee and the practice-related presentations will be selected by the following Co-Chairs:
Henry Brodaty, University of New South Wales, Sydney, NSW, Australia
Laura N. Gitlin Johns Hopkins School of Nursing, Baltimore, MD, United States
Mary E. Schulz, Alzheimer Society of Canada, Toronto, ON, Canada
Good to see some of the "oldtimers" back posting. Everyone have a great July 4th weekend and enjoy the freedom we still have in the good old USA. And for those living in other parts of the world be safe.
My bad... I guess I assumed exhibits and posters were the same.
I just emailed AAIC and asked that question.. I am Hoping the Late breaking has been determined and they will combine the posters for a presentation.
Anavex not listed on exhibitors list....
http://iebms.heiexpo.com/iebms/oep/oep_p5_floorplan.aspx?oc=62&ct=OEP&eventid=5004
Keep in mind all these "financial news feeds and advisers' get no benefit ($$$$$$) from pushing Anavex. Big Pharma owns them. JMO
Thanks I man
R U selling some?
Getting ready to wipe it out to 6.15
My guess is Phase 2 Retts study will be announced before July conference and we should hear something from Mike fox soon. As far as getting to $10, it is anyone's guess. A late breaking PR for AAIC would help.
https://ep70.eventpilotadmin.com/web/planner.php?id=AAIC16lite
put anavex in the search for agenda
I still believe he will come up with PR's that cut the legs off of Papa Troll and cause all the shorty's to cover.. hope is eternal..
I think we have a shot at late breaking
Developing Topic submissions are designed to bring the latest research findings in the field to AAIC attendees. Specifically, Developing Topic abstracts present research findings that were not available at the time of the general abstract submission deadline in February.
Note: AAIC 2016 Developing Topic abstracts will be considered for poster presentation only unless the research is considered to be late-breaking.
Criteria:
1 Late-breaking research/newness of information.
2 Potential impact on the research community.
3 Quality of scientific research.
4 Relevance to Alzheimer's disease and related disorders.
5 Topics of interest include basic and translational science, diagnosis and prognosis, therapeutics, and public health and psychosocial issues.
Missling is now listed as presenting both.
CONFIRMATION
Safety and Efficacy 31 Week Data of Anavex 2-73 in a Phase 2a Study in Mild-Moderate Alzheimer’s Disease Patients
The Good Doctor presenting
https://ep70.eventpilotadmin.com/web/planner.php?id=AAIC16lite
search for anavex
My guess is the Good Doctor has a surprise for you and your shorty friends this time....
First Clay now thestreet...WTF?
https://www.thestreet.com/story/13619956/2/these-5-stocks-are-ready-to-break-out-now.html
Russel re-balance day... should be positive for avxl
I think they do a late breaking as they did last year. Not sure if Missling will present. We should get a PR before the end of June... Time will tell ..greatness takes time.